propentofylline has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Liu, Z; Ren, W; Shi, M; Wei, C; Wu, X; Yang, M; Zhang, X | 1 |
1 other study(ies) available for propentofylline and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acids; Analysis of Variance; Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Down-Regulation; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; In Vitro Techniques; Male; Morphine; Narcotics; Neurons; Neuroprotective Agents; Nucleus Accumbens; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Synapses; Xanthines | 2012 |